Insulin delivery technology and eating behaviours in people with type 1 diabetes
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes
McGill University · NCT07348432
This project will test whether automated insulin delivery systems change eating behaviours and make carbohydrate counting easier for people aged 12 and older who have type 1 diabetes in Canada.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 106 (estimated) |
| Ages | 12 Years and up |
| Sex | All |
| Sponsor | McGill University (other) |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT07348432 on ClinicalTrials.gov |
What this trial studies
This is a cross-sectional observational study comparing people with type 1 diabetes who use automated insulin delivery (AID) systems to those using non-automated delivery. The study measures disordered eating behaviours, carbohydrate counting accuracy, and glycemic stability, and looks for differences by gender and by age group including youth (12–17 years). Participants provide data via smartphone apps and existing glucose/insulin device records, and carbohydrate-counting inaccuracy thresholds for maintaining glucose control will be estimated for each delivery type. The goal is to understand whether AID use is linked to lower food-management burden or different patterns of disordered eating.
Who should consider this trial
Good fit: Ideal candidates are people aged 12 or older living in Canada with type 1 diabetes for more than one year who use at least two daily insulin injections or an insulin pump and have used their current insulin delivery system for three months or more.
Not a fit: People who are pregnant or breastfeeding, do not speak English or French, lack a smartphone, or live outside Canada are not eligible and therefore will not benefit from participation in this study.
Why it matters
Potential benefit: If successful, the findings could help tailor diabetes technology choices and education to reduce eating-related burden and lower risk of disordered eating while maintaining glucose control.
How similar studies have performed: Previous studies show AID systems improve glycemic control and quality of life, but their specific effects on eating behaviours and disordered eating are largely untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 12 years of age or older * Living in Canada * Living with type 1 diabetes for more than 1 year * Using at least 2 insulin injections per day or using an insulin pump * Using current insulin delivery system for 3 months or more Exclusion Criteria: * Are pregnant or currently are breastfeeding * Don't speak French or English * Does not have a smart phone (to download applications)
Where this trial is running
Montreal, Quebec
- McGill University — Montreal, Quebec, Canada (RECRUITING)
Study contacts
- Principal investigator: Anne-Sophie Brazeau, PhD — McGill University
- Study coordinator: Courtney South, MSc
- Email: courtney.south@mail.mcgill.ca
- Phone: 705-527-4843
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Insulin Dependent Diabetes Mellitus, Feeding and Eating Disorders, Eating Behavior, Type 1 Diabetes, Autoimmune Diseases, Endocrine System Diseases, Automated Insulin Delivery, Disordered Eating Behaviours